GlassScriptPhysician profile
Dennis Edward Carson
NPI 1982816294
$15,473.78
in general payments reported to CMS, 2019-2025
50 companies · $1,966 in 2025
The $1,966 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,939 · 2020: $2,367 · 2021: $1,960 · 2022: $2,058 · 2023: $2,178 · 2024: $2,006 · 2025: $1,966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,150.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,507.11 | 2019-2025 | Vraylar, Ubrelvy, Synthroid |
| Astrazeneca Pharmaceuticals LP | $1,408.35 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $1,312.09 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $1,208.59 | 2019-2025 | |
| Lilly USA, LLC | $1,048.38 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $923.99 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $738.94 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Janssen Pharmaceuticals, INC | $716.12 | 2019-2025 | Spravato, Xarelto |
| Otsuka America Pharmaceutical, INC. | $609.54 | 2021-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $598.83 | 2019-2025 | Jardiance, Ofev |
| Teva Pharmaceuticals USA, INC. | $538.80 | 2019-2023 | Airduo Digihaler |
| Amgen INC. | $497.59 | 2019-2025 | Repatha, Evenity, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $479.04 | 2019-2025 | Xifaxan, Trulance |
| E.R. Squibb & Sons, L.L.C. | $409.17 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $330.28 | 2019-2024 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $298.95 | 2022-2025 | Keveyis, Gvoke Hypopen, Recorlev |
| Astellas Pharma US INC | $297.14 | 2019-2025 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $296.27 | 2019-2021 | |
| Dexcom, INC. | $252.11 | 2022-2025 | Dexcom G6 Transmitter |
| Phathom Pharmaceuticals, INC. | $225.35 | 2024-2025 | Voquezna |
| Allergan, INC. | $193.00 | 2019-2020 | |
| Exact Sciences Corporation | $167.28 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $162.62 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $162.09 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $135.29 | 2021 | |
| Jazz Pharmaceuticals INC. | $126.73 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $100.13 | 2022 | |
| Sanofi Pasteur INC. | $76.00 | 2019-2025 | |
| Eisai INC. | $73.85 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $56.58 | 2023-2024 | Gemtesa |
| Abbott Laboratories | $53.22 | 2021-2022 | |
| Halozyme INC | $47.82 | 2023 | |
| Esperion Therapeutics, INC. | $41.54 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $36.54 | 2019-2022 | |
| Antares Pharma, INC. | $36.25 | 2024 | Xyosted |
| Genentech USA, INC. | $33.49 | 2020-2021 | |
| Lundbeck LLC | $29.67 | 2022-2023 | Rexulti |
| Endo Pharmaceuticals INC. | $28.28 | 2020-2021 | |
| Corium, LLC | $27.72 | 2024 | Azstarys |
| Axsome Therapeutics, INC. | $26.64 | 2025 | Auvelity |
| Corcept Therapeutics | $23.34 | 2025 | Korlym |
| Harmony Biosciences LLC | $22.99 | 2024 | |
| Impel Pharmaceuticals LLC | $19.12 | 2025 | Trudhesa |
| Dynavax Technologies Corporation | $16.58 | 2022 | |
| Paratek Pharmaceuticals, INC. | $15.30 | 2023 | Nuzyra |
| Ucb, INC. | $15.20 | 2023 | Nayzilam |
| Sunovion Pharmaceuticals INC. | $13.43 | 2022 | |
| Cranial Technologies, INC | $12.70 | 2022 | |
| Amneal Pharmaceuticals LLC | $12.50 | 2019 | |
| Ibsa Pharma INC. | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.